EMS: Hypertension trials

The registry lists 15 Hypertension studies with EMS as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 2 2Phase 3 12No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled HypertensionNot yet recruitingNCT07030101Phase 3
• Efficacy and Safety of Atenas Association in the Treatment of Type II Diabetes Mellitus and HypertensionWithdrawnNCT05144360Phase 3
• Treatment of Resistant Hypertension: Cohort StudyCompletedNCT05087940
• Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and HypertensionWithdrawnNCT04970108Phase 3
• Efficacy and Safety of Leningrado 5 Association in the Treatment of HypertensionWithdrawnNCT03814148Phase 3
• Efficacy and Safety of Leningrado Association in the Treatment of HypertensionWithdrawnNCT03814109Phase 3
• Efficacy of Fixed-doses of Antihypertensive and Statin DrugsWithdrawnNCT03401580Phase 2
• BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular HypertensionCompletedNCT03235232Phase 3
• Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.WithdrawnNCT02662894Phase 3
• Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension ControlWithdrawnNCT02521246Phase 3
• Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension ControlWithdrawnNCT02521233Phase 3
• Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension ControlWithdrawnNCT02483936Phase 3
• Study to Assess Acute Vasodilation Response of Inhaled Nitric OxideWithdrawnNCT02436512Phase 3
• Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension TreatmentSuspendedNCT01620788Phase 3
• Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.CompletedNCT01265888Phase 2